Senzer, Neil
Gradalis, Inc,
United States
2024 Rank: 138206
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 5217 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 138206 | 145834 |
| Total Cites | 8961 | 9980 |
| H-index | 44 | 45 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 81 | 81 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 1110 | 1300 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 1282 | 1485 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7830 | 8386 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.19 |
| Self-Citation Percentage |
10.21%
|
|
Senzer, Neil
Gradalis, Inc,
United States
2023 Rank: 133293
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 5092 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 133293 | 139320 |
| Total Cites | 8412 | 9382 |
| H-index | 43 | 45 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 79 | 79 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 1056 | 1234 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 1215 | 1404 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7344 | 7876 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.19 |
| Self-Citation Percentage |
10.34%
|
|
Senzer, Neil
Gradalis, Inc,
United States
2022 Rank: 131544
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 5019 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 131544 | 137434 |
| Total Cites | 7645 | 8545 |
| H-index | 40 | 44 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 75 | 75 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 975 | 1136 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 1114 | 1283 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6667 | 7163 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.19 |
| Self-Citation Percentage |
10.53%
|
|
Senzer, Neil
Gradalis, Inc,
United States
2021 Rank: 125671
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 4853 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 125671 | 134214 |
| Total Cites | 7262 | 8123 |
| H-index | 41 | 43 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 74 | 74 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 948 | 1100 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 1080 | 1241 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6322 | 6800 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.19 |
| Self-Citation Percentage |
10.60%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.